source
- Q&A: Seaport CEO and CSO on learning from Karuna and the future of CNS researchSeaport Therapeutics began trading as a public company on Friday after executives rang the Nasdaq’s opening bell. Shares rose {$SPTX} more than 20%. With a team largely made up of Karuna Therapeuti…Endpoints · 3mo ago↗ source
- PFAS is still in some infant formulaCasey Means out as surgeon general nominee, America's renewed fertility anxiety, and more health newsSTAT · 3mo ago↗ source
- Two biotechs raise a combined $556M in latest spurt of IPOsSeaport Therapeutics and Hemab Therapeutics on Thursday became the latest drugmakers to debut on Wall Street, continuing a stretch of large IPOs this year that collectively raised almost $3.2 billion.BioPharma Dive · 3mo ago